Fig. 4

The comparison of the scale scores on the Medical Outcomes Study 36-Item Short Form 3 months after the initiation of sirolimus gel treatment for facial angiofibroma associated with tuberous sclerosis complex between patients with and without treatment-related adverse events. PF, physical function; RP, role limitations because of physical health problems; BP, bodily pain; GH, general health perception; VT, vitality; SF, social function; RE, role limitations because of emotional problems; MH, mental health. There were no significant differences in any scale scores between these two groups